Michael Bishop

Michael Bishop has extensive expertise in harnessing allogeneic immune responses for pediatric cancer treatment, combining stem cell transplantation with post-transplant immunotherapy strategies to maximize graft-versus-leukemia effects. His clinical research has optimized donor lymphocyte infusion protocols and post-transplant immune reconstitution approaches for pediatric patients. He has been instrumental in developing risk-adapted transplant strategies that integrate immunotherapy into the treatment paradigm.